Article by Kate Robertson, Lift News Canadian licensed cannabis producer Aurora has reached an agreement with the board of directors at CanniMed Therapeutics to acquire the company in full after two months of intense negotiations. CanniMed shareholders could receive 3.40 Aurora shares for each CanniMed share or a combination of shares and cash, to a maximum … Continue reading Billion-Dollar CanniMed Acquisition Strengthens Aurora’s International and Domestic Medical Cannabis Strategy